Travel Immunization
While travelling, getting vaccinated will keep you safe and healthy. Travelling to some countries require proof of vaccination for certain diseases like yellow fever or polio. In case of pregnant women, additional vaccines are needed to protect from ongoing illness or weakened immune system. It is required to get vaccinated at least 4-6 weeks before you travel.
- Japanese Encephalitis
- Meningococcal Infection
- Meningococcal Infection
Related Conference of Travel Immunization
August 27-28, 2026
7th International conference on Vaccines, Vaccination and Immunization
Paris, France
March 24-25, 2027
10th International Conference on Vaccines, Immunology and Clinical Trials
Paris, France
Travel Immunization Conference Speakers
Recommended Sessions
- Adaptive immune system
- Autoimmune and Inflammatory Diseases
- Diabetes Vaccines
- Haematopoietic, Lymphoid Malignancies and Immune System Development
- HIV Vaccines
- How deadly is the Coronavirus?
- Human Vaccines-Infectious and Non Infectious
- Immunization and Bioterrorism
- Immunogenetics
- Immunotherapy
- Nanotechnology in Vaccine Delivery System
- Pediatric Vaccination
- Travel Immunization
- Vaccination for pregnant women
- Vaccine Adjuvants and Delivery Technologies
- Vaccines and Immunization
- Vaccines for Immune mediated Disease
- Vaccines for Unconventional Diseases
- Vaccines Preclinical and Clinical Trials
- Veterinary Vaccines
Related Journals
Are you interested in
- Adaptive Immunity and Immune Memory Formation - WORLD VACCINES 2026 (France)
- Adjuvants and Immune Modulation Strategies - WORLD VACCINES 2026 (France)
- Adverse reactions to the vaccination - Vaccines Congress-2026 (UK)
- Animal & Plant Derived Vaccines - Vaccines-Immunization-2026 (France)
- Animal Models & Clinical Trials - Vaccines-Immunization-2026 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2026 (France)
- Antinatal vaccinations - Vaccines Congress-2026 (UK)
- Bacterial Vaccines and Toxoid Development - WORLD VACCINES 2026 (France)
- Bioinformatics and AI in Vaccine Design - Vaccine Immunology 2026 (Canada)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2026 (France)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2026 (France)
- Challenges in Vaccine Accessibility and Equity - Vaccine Immunology 2026 (Canada)
- Clinical Vaccinology and Immunotherapy - Vaccine Immunology 2026 (Canada)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2026 (France)
- Computational Immunology and Vaccine Modeling - WORLD VACCINES 2026 (France)
- Conjugated and combination vaccinations - Vaccines Congress-2026 (UK)
- Creation and development of vaccines - Vaccines Congress-2026 (UK)
- Current Research & Future Challenges - Vaccines-Immunization-2026 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2026 (France)
- DNA, RNA & SYNTHETIC VACCINES - Vaccines Congress-2026 (UK)
- Emerging and Re-Emerging Infectious Diseases - WORLD VACCINES 2026 (France)
- Emerging Infectious Diseases - Vaccine Immunology 2026 (Canada)
- Fish & Poultry Vaccines - Vaccines-Immunization-2026 (France)
- Future Directions in Vaccine Research - Vaccine Immunology 2026 (Canada)
- Future Directions in Vaccines and Immunology - WORLD VACCINES 2026 (France)
- Geriatric Immunization - Vaccines-Immunization-2026 (France)
- Global Vaccination Strategies - Vaccine Immunology 2026 (Canada)
- HIV , Malaria & TB vaccines - Vaccines Congress-2026 (UK)
- HIV Vaccines - Vaccines-Immunization-2026 (France)
- Human Microbiome and Vaccines - Vaccine Immunology 2026 (Canada)
- Immunogenetics and Host Immune Variability - WORLD VACCINES 2026 (France)
- Immunogenetics and Personalized Vaccines - Vaccine Immunology 2026 (Canada)
- Immunogenetics and Personalized Vaccines - Vaccine Immunology 2026 (Canada)
- Immunology and Immune System Innovations - Vaccine Immunology 2026 (Canada)
- Immunology of Infectious Diseases - Vaccine Immunology 2026 (Canada)
- Immunopathology and Vaccine Safety - WORLD VACCINES 2026 (France)
- Immunotherapy and Vaccines for Non-Infectious Diseases - Vaccine Immunology 2026 (Canada)
- Immunotherapy in Cancer Treatment - Vaccine Immunology 2026 (Canada)
- Industry and Technology Innovations - Vaccine Immunology 2026 (Canada)
- Innate Immune Responses in Vaccination - WORLD VACCINES 2026 (France)
- Maternal, Neonatal, and Geriatric Immunization - Vaccine Immunology 2026 (Canada)
- Microbiome-Targeted Vaccines - Vaccine Immunology 2026 (Canada)
- mRNA Vaccines and Nucleic Acid Platforms - WORLD VACCINES 2026 (France)
- Mucosal Immunity and Alternative Vaccine Routes - WORLD VACCINES 2026 (France)
- Nanotechnology and Advanced Delivery Systems - Vaccine Immunology 2026 (Canada)
- Nanotechnology in Vaccine Delivery - Vaccine Immunology 2026 (Canada)
- Next-Generation Vaccine Platforms - Vaccine Immunology 2026 (Canada)
- Novel Vaccine Platforms: mRNA, DNA, and Viral Vectors - Vaccine Immunology 2026 (Canada)
- One Health Approach to Vaccine Development - Vaccine Immunology 2026 (Canada)
- Paediatric Vaccination - Vaccines-Immunization-2026 (France)
- Pandemic Preparedness and Response - Vaccine Immunology 2026 (Canada)
- Pediatric and Geriatric Immunization Strategies - WORLD VACCINES 2026 (France)
- Public Health and Global Immunization - Vaccine Immunology 2026 (Canada)
- rDNA technology in vaccine development - Vaccines Congress-2026 (UK)
- Recent advances in vaccine development - Vaccines Congress-2026 (UK)
- Regulatory Science and Vaccine Approval Pathways - WORLD VACCINES 2026 (France)
- The COVID-19 vaccine's next-generation RNA platforms and mRNA - Vaccines Congress-2026 (UK)
- The Economics of Vaccination - Vaccine Immunology 2026 (Canada)
- Toxoid vaccination - Vaccines Congress-2026 (UK)
- Translational Vaccinology from Research to Practice - WORLD VACCINES 2026 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2026 (France)
- Vaccine and Vaccination - Vaccines Congress-2026 (UK)
- Vaccine Biomarkers and Immune Correlates - WORLD VACCINES 2026 (France)
- Vaccine Delivery Systems and Targeting Approaches - WORLD VACCINES 2026 (France)
- Vaccine Design and Antigen Engineering - WORLD VACCINES 2026 (France)
- Vaccine efficiency and well-being - Vaccines Congress-2026 (UK)
- Vaccine for infectious illnesses in humans - Vaccines Congress-2026 (UK)
- Vaccine Hesitancy and Public Trust - Vaccine Immunology 2026 (Canada)
- Vaccine Manufacturing and Scale-Up Technologies - WORLD VACCINES 2026 (France)
- Vaccine manufacturing technologies - Vaccines Congress-2026 (UK)
- Vaccine Production & Development - Vaccines-Immunization-2026 (France)
- Vaccine Production and Global Supply Chains - Vaccine Immunology 2026 (Canada)
- Vaccine Research and Clinical trials - Vaccines Congress-2026 (UK)
- Vaccine Research and Development - Vaccine Immunology 2026 (Canada)
- Vaccine Safety and Adverse Event Monitoring - Vaccine Immunology 2026 (Canada)
- Vaccine Safety, Pharmacovigilance, and Adverse Event Monitoring - Vaccine Immunology 2026 (Canada)
- Vaccine-Induced Cellular Immunity - WORLD VACCINES 2026 (France)
- Vaccine-Induced Immunity and Duration of Protection - Vaccine Immunology 2026 (Canada)
- Vaccines - Vaccines-Immunization-2026 (France)
- Vaccines & Autism - Vaccines-Immunization-2026 (France)
- Vaccines against Drugs - Vaccines-Immunization-2026 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2026 (France)
- Vaccines against non-traditional illnesses - Vaccines Congress-2026 (UK)
- VACCINES FOR CANCER - Vaccines Congress-2026 (UK)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2026 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2026 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2026 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2026 (France)
- Viral Vaccine Platforms and Vector Technologies - WORLD VACCINES 2026 (France)
- Zika Virus vaccines - Vaccines Congress-2026 (UK)